- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03372551
Comparison of Somofilcon A Daily Disposable Test Contact Lens and Somofilcon A Daily Disposable Control Contact Lens
July 9, 2019 updated by: CooperVision, Inc.
Comparison of Daily Disposable Invigor I (Test) and Select 1 Day Lenses
The purpose of this study is to investigate the overall clinical performance of the somofilcon A daily disposable test soft contact lens compared to the somofilcon A daily disposable control soft contact lens.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to evaluate the clinical performance of an investigational silicone-hydrogel contact lens (test) against a marketed silicone-hydrogel contact lens (control) when worn on a daily disposable wear modality over 1 week (for each lens) in a randomized, bilateral, cross-over, dispensing study.
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Waterloo, Ontario, Canada, N2L 3G1
- Center for Contact Lens Research, University of Waterloo
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
17 years and older (ADULT, OLDER_ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Is at least 17 years of age and has full legal capacity to volunteer;
- Has had a self-reported oculo-visual examination in the last two years;
- Has read, understood, and signed the information consent letter;
- Is willing and able to follow instructions and maintain the appointment schedule;
- Has a visual acuity of 20/30 or better (in each eye) with their habitual vision correction, or 20/20 best-corrected vision (for binocular distance acuity);
- Must be able to achieve 20/30 or better (in each eye) with the study lenses;
- Currently wears soft contact lenses for at least 3 days per week, 8 hours each day;
- Requires spectacle lens powers between -0.75 and -06.50 diopters sphere (0.25D steps);
- Has no more than 0.75 diopters of refractive astigmatism;
- Has clear corneas and no active* ocular disease;
- Has not worn lenses for at least 12 hours before the examination.
Exclusion Criteria:
- Is presently participating in any other clinical or research study including eye related clinical or research study;
- Has never worn contact lenses before.
- Has any systemic disease affecting ocular health.
- Has any active* ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect the wearing of contact lenses.
- Is using any systemic or topical medications that will affect a study outcome variable, and/or ocular health.
- Has any known sensitivity to fluorescein dye or products to be used in the study.
- Has persistent, clinically significant corneal or conjunctival staining using sodium fluorescein dye.
- Has any clinically significant lid or conjunctival abnormalities, active neovascularization or any central corneal scars.
- Is aphakic.
- Has undergone corneal refractive surgery.
- Is pregnant, lactating, or planning a pregnancy at the time of enrolment (by verbal confirmation at the screening visit).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: somofilcon A 1 day test lens
Subjects wearing the somofilcon A 1 day test lens for one week, either randomized as the first or second pair.
|
Contact lens
Other Names:
Contact lens
Other Names:
|
|
ACTIVE_COMPARATOR: somofilcon A 1 day control lens
Subjects wearing the somofilcon A 1 day control lens for one week, either randomized as the first or second pair.
|
Contact lens
Other Names:
Contact lens
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comfort
Time Frame: up to 1 week
|
Subjective comfort scored 0-100 (0=Cannot be worn, 100=Cannot be felt ever)
|
up to 1 week
|
|
Preference
Time Frame: up to 1 week
|
Overall lens that subject prefers or no preference
|
up to 1 week
|
|
Vision
Time Frame: Up to 1 week
|
Visual acuity measured in logMAR
|
Up to 1 week
|
|
Subjective Vision
Time Frame: up to 1 week
|
Subjective vision scored 0-100 (0=Extremely poor, 100=Excellent vision all the time)
|
up to 1 week
|
|
Corneal Staining
Time Frame: up to 1 week
|
Amount of staining observed on the cornea scored 0-4 (0=none, 4=severe) in 0.25 steps
|
up to 1 week
|
|
Conjunctival Staining
Time Frame: up to 1 week
|
Amount of staining observed on the conjunctiva scored 0-4 (0=none, 4=severe) in 0.25 steps
|
up to 1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 29, 2017
Primary Completion (ACTUAL)
December 22, 2017
Study Completion (ACTUAL)
April 23, 2018
Study Registration Dates
First Submitted
December 8, 2017
First Submitted That Met QC Criteria
December 8, 2017
First Posted (ACTUAL)
December 13, 2017
Study Record Updates
Last Update Posted (ACTUAL)
July 23, 2019
Last Update Submitted That Met QC Criteria
July 9, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-16-43
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
-
Shanghai 10th People's HospitalCompletedMyopia | Myopia, ProgressiveChina
-
Tianjin Eye HospitalActive, not recruiting
Clinical Trials on somofilcon A 1 day test lens
-
CooperVision, Inc.CompletedMyopiaUnited States
-
CooperVision, Inc.CompletedAmetropiaUnited Kingdom
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision International Limited (CVIL)Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Centre for Ocular Research & Education, CanadaCompleted
-
CooperVision International Limited (CVIL)University of California, BerkeleyCompletedPresbyopia | Myopia | HyperopiaUnited States
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed